Literature DB >> 30212861

Depressive symptomatology in school-aged children with obstructive sleep apnea syndrome: incidence, demographic factors, and changes following a randomized controlled trial of adenotonsillectomy.

Elise Hodges1, Carole L Marcus2,3, Ji Young Kim3, Melissa Xanthopoulos4, Justine Shults5, Bruno Giordani1, Dean W Beebe6, Carol L Rosen7, Ronald D Chervin8, Ron B Mitchell9, Eliot S Katz10, David Gozal11, Susan Redline12,13,14, Lisa Elden15, Raanan Arens16, Renee Moore17, H Gerry Taylor18,19, Jerilynn Radcliffe2,5, Nina H Thomas4,5.   

Abstract

Study
Objectives: Depressive symptoms following adenotonsillectomy (AT) relative to controls were examined in children with obstructive sleep apnea syndrome (OSAS).
Methods: The Childhood Adenotonsillectomy Trial (CHAT) multisite study examined the impact of AT in 453 children aged 5 to 9.9 years with polysomnographic evidence of OSAS without prolonged desaturation, randomized to early adenotonsillectomy (eAT) or watchful waiting with supportive care (WWSC). One hundred seventy-six children (eAT n = 83; WWSC n = 93) with complete evaluations for depressive symptomatology between baseline and after a 7-month intervention period were included in this secondary analysis.
Results: Exact binomial test assessed proportion of depressive symptomatology relative to norms, while effects of AT and OSAS resolution were assessed through linear quantile mixed-models. Treatment group assignment did not significantly impact depression symptoms, although self-reported depression symptoms improved over time (p < 0.001). Resolution of OSAS symptoms demonstrated a small interaction effect in an unexpected direction, with more improvement in parent ratings of anxious/depressed symptoms for children without resolution (p = 0.030). Black children reported more severe depressive symptoms (p = 0.026) and parents of overweight/obese children reported more withdrawn/depressed symptoms (p = 0.004). Desaturation nadir during sleep was associated with self-report depressed (r = -0.17, p = 0.028), parent-reported anxious/depressed (r = -0.15, p = 0.049), and withdrawn/depressed (r = -0.24, p = 0.002) symptoms. Conclusions: Increased risk for depressed and withdrawn/depressed symptoms was detected among children with OSAS, and different demographic variables contributed to risk in self-reported and parent-reported depression symptoms. Arterial oxygen desaturation nadir during sleep was strongly associated with depressed symptoms. However, despite improvements in child-reported depressed symptoms over time, changes were unrelated to either treatment group or OSAS resolution status. Trials Registration: Childhood Adenotonsillectomy Study for Children with OSAS (CHAT), https://clinicaltrials.gov/show/NCT00560859, NCT00560859.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30212861      PMCID: PMC6289235          DOI: 10.1093/sleep/zsy180

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  18 in total

1.  The Childhood Adenotonsillectomy Trial (CHAT): rationale, design, and challenges of a randomized controlled trial evaluating a standard surgical procedure in a pediatric population.

Authors:  Susan Redline; Raouf Amin; Dean Beebe; Ronald D Chervin; Susan L Garetz; Bruno Giordani; Carole L Marcus; Renee H Moore; Carol L Rosen; Raanan Arens; David Gozal; Eliot S Katz; Ronald B Mitchell; Hiren Muzumdar; H G Taylor; Nina Thomas; Susan Ellenberg
Journal:  Sleep       Date:  2011-11-01       Impact factor: 5.849

2.  Effects of Adenotonsillectomy on Parent-Reported Behavior in Children With Obstructive Sleep Apnea.

Authors:  Nina Hattiangadi Thomas; Melissa S Xanthopoulos; Ji Young Kim; Justine Shults; Emma Escobar; Bruno Giordani; Elise Hodges; Ronald D Chervin; Shalini Paruthi; Carol L Rosen; Gerry H Taylor; Raanan Arens; Eliot S Katz; Dean W Beebe; Susan Redline; Jerilynn Radcliffe; Carole L Marcus
Journal:  Sleep       Date:  2017-04-01       Impact factor: 5.849

3.  Childhood and adolescent depression: child-report versus parent-report information.

Authors:  M M Moretti; S Fine; G Haley; K Marriage
Journal:  J Am Acad Child Psychiatry       Date:  1985-05

4.  Age, gender, race, socioeconomic status, and birth cohort differences on the children's depression inventory: a meta-analysis.

Authors:  Jean M Twenge; Susan Nolen-Hoeksema
Journal:  J Abnorm Psychol       Date:  2002-11

5.  Cognitive Effects of Adenotonsillectomy for Obstructive Sleep Apnea.

Authors:  H Gerry Taylor; Susan R Bowen; Dean W Beebe; Elise Hodges; Raouf Amin; Raanan Arens; Ronald D Chervin; Susan L Garetz; Eliot S Katz; Reneé H Moore; Knashawn H Morales; Hiren Muzumdar; Shalini Paruthi; Carol L Rosen; Anjali Sadhwani; Nina Hattiangadi Thomas; Janice Ware; Carole L Marcus; Susan S Ellenberg; Susan Redline; Bruno Giordani
Journal:  Pediatrics       Date:  2016-08       Impact factor: 7.124

6.  The relationship between depressive symptoms and obstructive sleep apnea in pediatric populations: a meta-analysis.

Authors:  Elif Yilmaz; Karim Sedky; David S Bennett
Journal:  J Clin Sleep Med       Date:  2013-11-15       Impact factor: 4.062

7.  Parent-Child Discrepancies in Reporting of Child Depression in Ethnic Groups.

Authors:  JaHun Kim; Ya-Fen Chan; Elizabeth McCauley; Ann Vander Stoep
Journal:  J Nurse Pract       Date:  2016-06       Impact factor: 0.767

8.  A randomized trial of adenotonsillectomy for childhood sleep apnea.

Authors:  Carole L Marcus; Reneé H Moore; Carol L Rosen; Bruno Giordani; Susan L Garetz; H Gerry Taylor; Ron B Mitchell; Raouf Amin; Eliot S Katz; Raanan Arens; Shalini Paruthi; Hiren Muzumdar; David Gozal; Nina Hattiangadi Thomas; Janice Ware; Dean Beebe; Karen Snyder; Lisa Elden; Robert C Sprecher; Paul Willging; Dwight Jones; John P Bent; Timothy Hoban; Ronald D Chervin; Susan S Ellenberg; Susan Redline
Journal:  N Engl J Med       Date:  2013-05-21       Impact factor: 91.245

9.  DSM-IV diagnoses and obstructive sleep apnea in children before and 1 year after adenotonsillectomy.

Authors:  James E Dillon; Sarah Blunden; Deborah L Ruzicka; Kenneth E Guire; Donna Champine; Robert A Weatherly; Elise K Hodges; Bruno J Giordani; Ronald D Chervin
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-11       Impact factor: 8.829

10.  Pediatric sleep apnea and depressive disorders risk: A population-based 15-year retrospective cohort study.

Authors:  Chun-Hung Chang; Shaw-Ji Chen; Chieh-Yu Liu
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

View more
  5 in total

1.  Efficacy of a Pediatric Sleep Questionnaire for the Diagnosis of Obstructive Sleep Apnea in Children.

Authors:  Andrew M Ferry; Alex E Wright; Jason F Ohlstein; Kim Khoo; Harold S Pine
Journal:  Cureus       Date:  2020-12-23

Review 2.  The relationship between sleep and depression and bipolar disorder in children and young people.

Authors:  Monica Comsa; Kirstie N Anderson; Aditya Sharma; Vanishri C Yadav; Stuart Watson
Journal:  BJPsych Open       Date:  2022-01-14

3.  The Efficacy of Twin-Block Appliances for the Treatment of Obstructive Sleep Apnea in Children: A Systematic Review and Meta-Analysis.

Authors:  Jun Duan; Wanyuan Xia; Kai Yang; Xuelei Li; Feng Zhang; Jie Xu; Ying Jiang; Jia Liang; Bing Li
Journal:  Biomed Res Int       Date:  2022-07-11       Impact factor: 3.246

4.  Effect of adenotonsillectomy in children with obstructive sleep apnea and major psychiatric disorders on obstructive apnea-hypopnea index and Epworth Sleepiness Scale scores.

Authors:  Melissa Scholes; Emily Jensen; Maxene Meier; Norman Friedman
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.062

5.  Prevalence of Sleep-Disordered Breathing in Children Referring for First Dental Examination. A Multicenter Cross-Sectional Study Using Pediatric Sleep Questionnaire.

Authors:  Gabriele Di Carlo; Francesca Zara; Milena Rocchetti; Angelica Venturini; Antonio José Ortiz-Ruiz; Valeria Luzzi; Paolo Maria Cattaneo; Antonella Polimeni; Iole Vozza
Journal:  Int J Environ Res Public Health       Date:  2020-11-16       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.